Inhibition of miR-185-3p Confers Erlotinib Resistance Through Upregulation of PFKL/MET in Lung Cancers
Ke Li(Jiangsu Cancer Hospital), Conghu Yuan(Yancheng Third People's Hospital)
Cited by 16
Related Papers
HNRNPA2B1-mediated m6A modification of lncRNA MEG3 facilitates tumorigenesis and metastasis of non-small cell lung cancer by regulating miR-21-5p/PTEN axis
|Journal of Translational Medicine|2023|63